NCT00844402View on ClinicalTrials.gov

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Primary Biliary CirrhosisHypercholesterolemia
Interventions
DRUG

Atorvastatin

oral, 10 mg, daily, 48 weeks

Trial Locations (1)

8036

Department of Internal Medicine, Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT00844402 - Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter